FIELD: medicine. SUBSTANCE: method involves performing wedge resection of ovaries. Blood chemoluminescence is determined. Estrogen-gestagen preparations are administered for 3-4 months. Blood chemoluminescence is examined for the second time. Optic sum being equal to or less than 7.9 quants/min 106, the estrogen-gestagen preparations are cancelled. EFFECT: enhanced effectiveness in maintaining normal course of pregnancy. 1 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD OF DERMATOSIS DEVELOPMENT PREDICTION IN WOMEN WITH SCLEROPOLYCYSTIC OVARIAN SYNDROME (SPCO) | 2008 |
|
RU2367954C1 |
METHOD OF TREATMENT OF PATIENT WITH OVARY HYPERSTIMULATION SYNDROME | 1997 |
|
RU2143892C1 |
METHOD FOR TREATING CHRONIC ANOVULATION AND PREVENTING SYNDROME OF OVARIAN HYPERSTIMULATION | 1999 |
|
RU2201225C2 |
METHOD FOR APPLYING EXTRACORPORAL FERTILIZATION | 1999 |
|
RU2181581C2 |
METHOD FOR CARRYING OUT AN EXTRACORPORAL FERTILIZATION | 2000 |
|
RU2190978C2 |
METHOD OF TREATMENT OF PERINATAL CENTRAL NERVOUS SYSTEM DAMAGE IN NEWBORNS | 1995 |
|
RU2089189C1 |
METHOD OF TREATING POLYCYSTIC OVARY SYNDROME WITH NON-HORMONAL PREPARATIONS | 2020 |
|
RU2732688C1 |
METHOD OF TREATMENT OF CHRONIC GESTATION NONBEARING AT ADRENAL DISEASE | 1993 |
|
RU2089203C1 |
METHOD OF TREATING POLYCYSTIC OVARIAN SYNDROME IN ADOLESCENT GIRLS WITH USE OF NON-HORMONAL PREPARATIONS | 2014 |
|
RU2563181C1 |
METHOD OF DETERMINING LENGTH OF CERVIX UTERI | 1989 |
|
RU2023417C1 |
Authors
Dates
1998-07-27—Published
1995-12-22—Filed